BioBoard
•  Incitive to Prepare for IPO
•  Scigen Acquires Manufacturing Facility from Shreya Biotech
•  Taiwan's New Discovery on Cancer
•  Japan's Kissei Licenses Glufast to Elixir
•  Generic Pharma Giant Teva Increases Stake in Chinese Biotech Firm
•  Living Cell Technologies Awarded NZ$2.7 Million Investment through the Foundation for Research, Science and Technology
•  Bionomics Wins A$3.7 Million AusIndustry Grant
•  Singapore to Invest $7.5 Billion over Five Years on Research and Development
•  Queensland Projects Win A$1.6 million Funding

Special Feature
•  An Australian Vaccine Development Company -- Vaxine
•  Developing Vaccines for Infectious Diseases Prevalent to the Asia Pacific
•  Improving Manufacturing Technologies for New Generation Vaccines
•  NewBiomed PIKA, A Vaccine Company with a Bright Future
•  Synthetic Lipopeptide Vaccines

Industry Watch
•  CyGenics Expands Into Europe
•  Increasing US Investment Support for Starpharma
•  Proteomics -- An Australian-based Biotech Company
•  Resonance Health to Expand US Business Operations
•  Rockeby biomed Announces Four New Developments for Avian Influenza Test Kits
•  Ranbaxy Buys Companies in Belgium, Italy and Romania
•  Japan's Bioventures Today -- HuBit Genomix Inc
•  Abbott to Invest US$280 Million in the Largest Nutritional Plant in Singapore
•  Covance Celebrates 10th Anniversary Milestone in Singapore
•  NanoMaterials Technology Opens New S$2.5 Million Facility
•  Waters Corporation Collaborates with Solectron
•  Zentek Engineering Becomes First Irish Company to Set Up Asia Pacific HQ in Singapore

Research Findings
•  Gatekeeper Protein's Role in Rare Kidney Disease Unraveled
•  IBN's Hydrogel Could Lead to Better and Safer Disease Treatments

Agriculture
•  Forest Biotechnology is Beginning to Take Root

Conference Calendar